Information Provided By: 
Fly News Breaks for September 7, 2017
NUVA
Sep 7, 2017 | 12:13 EDT
Piper Jaffray analyst Matt O'Brien believes NuVasive's acquisition of Vertera, while small, is an "interesting technology/patent play for the long term." The analyst "strong" encourages investors take advantage of the recent pullback to start or build positions in the name. He keeps an Overweight rating on the shares with a $90 price target.
News For NUVA From the Last 2 Days
There are no results for your query NUVA
